Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
Clinical trial NCT07267221 · RECRUITING
Trial details
- NCT number
- NCT07267221
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2026-01-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.